Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Science Translational Medicine|September 14, 2018
Thrombopoietin receptor-independent stimulation of hematopoietic stem cells by eltrombopagYun-Ruei Kao, Jiahao Chen, Swathi-Rao Narayanagari, et al.
Blood Advances|July 24, 2023
Ciclopirox ethanolamine preserves the immature state of human HSCs by mediating intracellular iron contentMehrnaz Safaee Talkhoncheh, Aurélie Baudet, Fredrik Ek, et al.
Cell Stem Cell|November 5, 2016
Leukemic Stem Cells S(p)liced OffMargarida Ferreira-Teixeira, Britta Will
Blood|February 5, 2017
Stem and progenitor cell alterations in myelodysplastic syndromesAditi Shastri, Britta Will, Ulrich Steidl, et al.
Cell Stem Cell|February 25, 2024
An iron rheostat controls hematopoietic stem cell fateYun-Ruei Kao, Jiahao Chen, Rajni Kumari, et al.
Invertebrate Neuroscience : IN|November 25, 2010
Neuronal cell death during metamorphosis of Hydractina echinata (Cnidaria, Hydrozoa)Stefanie Seipp, Jürgen Schmich, Britta Will, et al.
The Journal of Clinical Investigation|July 17, 2012
Targeting CDK1 promotes FLT3-activated acute myeloid leukemia differentiation through C/EBPαHanna S Radomska, Meritxell Alberich-Jordà, Britta Will, et al.
Seminars in Hematology|December 15, 2019
Mechanisms and therapeutic prospects of thrombopoietin receptor agonistsJames Bussel, Austin Kulasekararaj, Nichola Cooper, et al.
Experimental Hematology|September 4, 2007
JAK2V617F-negative ET patients do not display constitutively active JAK/STAT signalingSven Schwemmers, Britta Will, Cornelius F Waller, et al.
Leukemia & Lymphoma|March 22, 2014
Eltrombopag can overcome the anti-megakaryopoietic effects of lenalidomide without increasing proliferation of the malignant myelodysplastic syndrome/acute myelogenous leukemia cloneRoni Tamari, Carolina Schinke, Tushar Bhagat, et al.
Pageof 7